Gadolinium Complex of 1,4,7,10-Tetraazacyclododecane-1,4,7-trisacetic Acid (DO3A)–Ethoxybenzyl (EOB) Conjugate as a New Macrocyclic Hepatobiliary MRI Contrast Agent-Reference-Cited by-同舟云学术

Gadolinium Complex of 1,4,7,10-Tetraazacyclododecane-1,4,7-trisacetic Acid (DO3A)–Ethoxybenzyl (EOB) Conjugate as a New Macrocyclic Hepatobiliary MRI Contrast Agent

Published:2017-05-31 Issue:12 Volume:60 Page:4861-4868
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Baek Ah Rum,Kim Hee-Kyung,Park Subin,Lee Gang Ho,Kang Hyo Jeung,Jung Jae-Chang,Park Joon-Suk¹,Ryeom Hun-Kyu,Kim Tae-Jeong,Chang Yongmin^ORCID

Affiliation:

1. Laboratory Animal Center, Daegu-Gyeongbuk Medical Innovation Foundation Chumbok-ro 80, Dong-gu, Daegu 41061, Korea

Funder

National Research Foundation of Korea

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.7b00060

Reference39 articles.

1. Morley, M.; Brooks, B.Release gadolinium may remain in brain after contrast MRI. RSNA Press Release, May 5, 2015.https://press.rsna.org/timssnet/media/pressreleases/14_pr_target.cfm?ID=810(accessed September 10, 2016).

2. What nephrologists need to know about gadolinium

3. Nephrogenic Systemic Fibrosis: Incidence, Associations, and Effect of Risk Factor Assessment—Report of 33 Cases

4. Nephrogenic Systemic Fibrosis and Gadolinium-Based Contrast Agents

5. The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced sensitivity of spectral CT imaging in vivo by using Ytterbium chelate;Chemical Engineering Journal;2024-10

2. Rational Design of Mono-Substituted Gd-DOTA as Highly Stable and Efficient MRI Contrast Agents for Hepatobiliary and Inflammation Imaging;Journal of Medicinal Chemistry;2024-08-27

3. Lipophilic Group-Modified Manganese(II)-Based Contrast Agents for Vascular and Hepatobiliary Magnetic Resonance Imaging;Journal of Medicinal Chemistry;2024-03-07

4. Chiral Gd-DOTA as a Versatile Platform for Hepatobiliary and Tumor Targeting MRI Contrast Agents;Journal of Medicinal Chemistry;2023-10-19

5. Rational Design of Gd-DOTA-Type Contrast Agents for Hepatobiliary Magnetic Resonance Imaging;Journal of Medicinal Chemistry;2023-06-28